First-of-its-kind NHS gene pilot takes off
The NHS launches world-first study investigating genetic testing for common diseases
18th January 2022
-
Pharmaceuticals in 2022
The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022
-
Why pharma needs to understand population health
Often misunderstood, the new focus on prevention and population health within the NHS can help pharma become a critical part of a more holistic, outcomes-led strategy for local systems, argues Oli Hudson
-
Inclusion zone
Nothing crystallises the need for diversity and inclusion quite like pharma – a dose of unity makes us all feel, work and collaborate better – and now we must prescribe it throughout our industry
News
View all
Air of optimism surrounds lung cancer vaccine
Cancer Research UK announces clinical trial for most common type of lung cancer
18th January 2022
CDI prevention reaches date with destiny
Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead
17th January 2022
Poolbeg Pharma dives into nasally administered antivirals
If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at
17th January 2022
Gates Foundation supports HIV and malaria research
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation
14th January 2022
Top trending
New study finds AstraZeneca booster generates higher antibodies against Omicron
Pregnant women urged to receive COVID-19 booster amid surging cases
UK government to cut cost of repeatable HRT prescriptions
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
AstraZeneca and Novavax say their vaccines are effective against Omicron
Chemotherapy causes death in more than 25% of cancer patients
Web Exclusives
View all
First-ever Parkinson’s Everest adventurer proves being remarkable does not change with a diagnosis
Alex Flynn was 36 when diagnosed with Parkinson’s in 2008 and has since raised around £400,000 in the last ten years
Magazine
View more from the latest edition
Patient file: Duchenne muscular dystrophy
PharmaTimes talks to Filippo Buccella, whose son Luca was diagnosed with the rare genetic disorder Duchenne muscular dystrophy (DMD) 28 years ago.He offers an in-depth look at Luca’s path to diagnosis, the treatment he has received as well as the advice he would offer to parents of a child with DMD.
Behavioural science: a new ally for Medical Affairs
Ben Routley and Mark Pringle take a look at how behavioural science techniques (BST) could be used to improve the impact of client communications
The ever-increasing importance of the patient’s voice
We are currently witnessing a significant shift in healthcare – the rise of the empowered patient
The ecosystem overtakes the producers in pharma and life sciences
M&A returns – but in a new form
Sustainability is the word
If there was a word to sum up healthcare communications in 2021 it would be ‘sustainability’…in all senses of the word
Pharmaceuticals in 2022
The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022
Maintaining the halo effect
What’s next for the pharmaceutical industry?
Thought Leadership
View all
Native advertising is exploding across healthcare, have you jumped in?
In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.
Improving waste management in pharmaceutical manufacturing
By Grace Oldham, Head of Business Development, at Axil Integrated Services
A life in a day
How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry
A ‘triple win’ for pharma
Patient centricity that delivers the ‘triple win’ is a business essential for pharma
Webinars
View all
Designing Pharma organisations for success
Wednesday, 28 September 2016 - 11:00 am
Across all industries, people are changing the ways they engage with products, services, and brands.
George Underwood
FREE - Listen again now - | VIEW NOW
Focusing on Patient-centricity for the Future of Pharma
Wednesday, 21 July 2021 - 2:00 pm
In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.
Mark Doyle, co-founder of The Method and creator of A Life in a Day
FREE | ATTEND
